23-10-30 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-08-03 GSK Nigeria calls an end to its business, to return cash RE
23-08-03 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
23-08-03 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
23-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-10-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
22-07-29 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
22-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
22-01-31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
21-10-25 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
21-07-29 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 2011-07-31
General Counsel - 2017-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
-2.33%-2.09%+49.88%+169.76% 1,060B
-0.82%-2.30%+63.79%+62.56% 619B
-0.73%-4.98%+28.91%+83.79% 438B
+0.33%-1.17%+31.07%+26.57% 333B
-0.02%-2.85%+29.15%+46.14% 282B
-3.89%-11.22%+22.81%+25.23% 267B
+0.66%-1.42%-26.59%-37.67% 218B
-0.06%-2.88%+23.07%+61.02% 196B
-3.72%-1.10%+18.41%+69.98% 161B
Average -1.06%-3.33%+26.72%+56.38% 397.1B
Weighted average by Cap. -1.31%-3.10%+36.75%+83.66%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock